Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Letter to the editor: Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization.

× No keyword cloud information.

10 in total

1. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.

Authors: C S Tan; M C Chew; T H Lim
Journal: Eye (Lond) Date: 2013-09-20 Impact factor: 3.775

2. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Authors: Kevin J Blinder; Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donato; Hilel Lewis; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi M Mones; Michael J Potter; Constantin Pournaras; Al Reaves; Philip Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenberg; Lawrence J Singerman; Jason S Slakter; H Andrew Strong; Gianni Virgili; George A Williams
Journal: Ophthalmology Date: 2003-04 Impact factor: 12.079

3. Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography - comparison of different methods.

Authors: Colin S Tan; Kelvin Z Li; Tock Han Lim
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-05-27 Impact factor: 3.117

4. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.

Authors: Yasushi Ikuno; Kyoko Ohno-Matsui; Tien Yin Wong; Jean-Francois Korobelnik; Robert Vitti; Tummy Li; Brigitte Stemper; Friedrich Asmus; Oliver Zeitz; Tatsuro Ishibashi
Journal: Ophthalmology Date: 2015-03-04 Impact factor: 12.079

5. Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes.

Authors: Colin S H Tan; Wei Kiong Ngo; Kai Xiong Cheong
Journal: Br J Ophthalmol Date: 2014-10-01 Impact factor: 4.638

6. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.

Authors: Hyun Seung Yang; June-Gone Kim; Jee Taek Kim; Soo Geun Joe
Journal: Am J Ophthalmol Date: 2013-09-25 Impact factor: 5.258

7. Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy.

Authors: Colin S Tan; Milton C Chew; Kai-Hung Lim; Tock-Han Lim
Journal: Int J Ophthalmol Date: 2013-06-18 Impact factor: 1.779

8. A novel technique of adjusting segmentation boundary layers to achieve comparability of retinal thickness and volumes between spectral domain and time domain optical coherence tomography.

Authors: Colin S H Tan; Kelvin Z Li; Tock Han Lim
Journal: Invest Ophthalmol Vis Sci Date: 2012-08-13 Impact factor: 4.799

9. Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization.

Authors: Elsa Bruyère; Violaine Caillaux; Salomon Yves Cohen; David Martiano; Raphaelle Ores; Nathalie Puche; Eric H Souied
Journal: Am J Ophthalmol Date: 2015-07-08 Impact factor: 5.258

10. Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization.

Authors: Claudio Traversi; Elisabetta Nuti; Davide Marigliani; Gabriele Cevenini; Angelo Balestrazzi; Gianluca Martone; Tomaso Caporossi; Gian Marco Tosi
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-07-13 Impact factor: 3.117

10 in total